{"id":"https://openalex.org/W2336442791","doi":"https://doi.org/10.1093/neuonc/nov204.68","title":"ATPS-68COMBINATION OF TOPOISOMERASE II POISON BERUBICIN WITH STAT3 INHIBITOR WP1066BLOCKS POTENTLY TUMOR GROWTH IN GMB MODELS","display_name":"ATPS-68COMBINATION OF TOPOISOMERASE II POISON BERUBICIN WITH STAT3 INHIBITOR WP1066BLOCKS POTENTLY TUMOR GROWTH IN GMB MODELS","publication_year":2015,"publication_date":"2015-11-01","ids":{"openalex":"https://openalex.org/W2336442791","doi":"https://doi.org/10.1093/neuonc/nov204.68","mag":"2336442791"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/nov204.68","doi":"https://doi.org/10.1093/neuonc/nov204.68","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nov204.68","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4638491","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101864816","display_name":"Rafal J. Zielinski","orcid":"https://orcid.org/0000-0001-5735-9119","observed_orcids":["https://orcid.org/0000-0001-5735-9119"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rafal Zielinski","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013970493","display_name":"Stanis\u0142aw Sk\u00f3ra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stanislaw Skora","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068661573","display_name":"Aleksandra Rusin","orcid":"https://orcid.org/0000-0003-0881-5995","observed_orcids":["https://orcid.org/0000-0003-0881-5995"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aleksandra Rusin","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055645760","display_name":"Izabela Fokt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Izabela Fokt","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079081497","display_name":"Amy B. Heimberger","orcid":"https://orcid.org/0000-0002-9970-8695","observed_orcids":["https://orcid.org/0000-0002-9970-8695"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Heimberger","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091806633","display_name":"Raymond A. Sawaya","orcid":"https://orcid.org/0000-0002-6035-7939","observed_orcids":["https://orcid.org/0000-0002-6035-7939"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond Sawaya","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062959791","display_name":"Waldemar Priebe","orcid":"https://orcid.org/0000-0003-4522-4772","observed_orcids":["https://orcid.org/0000-0003-4522-4772","https://orcid.org/0000-0003-3969-0144"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Waldemar Priebe","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":5.0605,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.96315128,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"17","issue":"suppl 5","first_page":"v33.2","last_page":"v33"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9301999807357788,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9301999807357788,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.06310000270605087,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/wp1066","display_name":"WP1066","score":0.972000002861023},{"id":"https://openalex.org/keywords/stat3-inhibitor","display_name":"STAT3 inhibitor","score":0.8109999895095825},{"id":"https://openalex.org/keywords/topoisomerase-ii-poisons","display_name":"topoisomerase II poisons","score":0.9269999861717224},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9089999794960022},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7870000004768372},{"id":"https://openalex.org/keywords/glioma-stem-cells","display_name":"glioma stem cells","score":0.8270000219345093},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6240000128746033},{"id":"https://openalex.org/keywords/blood-brain-barrier-penetration","display_name":"blood-brain barrier penetration","score":0.8700000047683716},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C2778923194","wikidata":"https://www.wikidata.org/wiki/Q14912019","display_name":"STAT3","level":3,"score":0.7150376439094543},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6779637336730957},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5510917901992798},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5312065482139587},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.527438223361969},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5112531185150146},{"id":"https://openalex.org/C128473837","wikidata":"https://www.wikidata.org/wiki/Q7863603","display_name":"U87","level":3,"score":0.45934897661209106},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.4414404332637787},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.42355209589004517},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4178367257118225},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38480401039123535},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.33031129837036133},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21343576908111572},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0676226019859314},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/nov204.68","doi":"https://doi.org/10.1093/neuonc/nov204.68","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nov204.68","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4638491","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4638491","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4638491","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4638491","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neuro Oncol","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.75,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2353888425","https://openalex.org/W2906781265","https://openalex.org/W2756398555","https://openalex.org/W2165296235","https://openalex.org/W2963339729","https://openalex.org/W2073311278","https://openalex.org/W3032021368","https://openalex.org/W2983142428","https://openalex.org/W4206633623","https://openalex.org/W2520037959"],"abstract_inverted_index":{"BACKGROUND:":[0],"Berubicin":[1],"(WP744)":[2],"is":[3,24,81,87,107,120,140,150,264],"a":[4,25,103,108,177,208,237,286],"DNA":[5],"binding":[6],"agent":[7,28],"and":[8,14,44,56,75,125,165,172,189,194,201,230,243,254,267],"potent":[9,26,109],"topoisomerase":[10],"II":[11],"poison":[12],"designed":[13,115],"synthesized":[15],"in":[16,32,48,68,89,116,130,157,161,163,166,176,210,215,224,236,273,285],"our":[17,117,268],"laboratory.":[18,118],"Preclinical":[19],"studies":[20],"demonstrated":[21,127,231],"that":[22,86,260],"WP744":[23,35,52,139,156,171,188,281],"anticancer":[27,128],"with":[29,159,256,283],"nanomolar":[30,200],"potency":[31],"glioma":[33,50],"cells.":[34],"was":[36,213,222],"shown":[37],"to":[38,138,142,151],"effectively":[39,191],"cross":[40,143],"blood-brain":[41],"barrier":[42],"(BBB)":[43],"displayed":[45],"antitumor":[46],"activity":[47,129,279],"orthotopic":[49],"models.":[51,169,277],"gained":[53],"IND":[54],"approval":[55],"subsequent":[57],"Phase":[58],"I":[59],"clinical":[60,63,297],"trials":[61],"shows":[62],"benefits":[64],"(including":[65],"complete":[66],"response)":[67],"selected":[69],"brain":[70,275],"tumor":[71,228,233,276],"patients.":[72],"Signal":[73],"Transducer":[74],"Activator":[76],"of":[77,97,105,111,147,155,179,241,280,289],"Transcription":[78],"3":[79],"(STAT3)":[80],"an":[82,95],"oncogenic":[83],"transcription":[84],"factor":[85],"activated":[88,112],"numerous":[90],"tumors":[91,290],"including":[92,134,183],"GBM.":[93,135],"WP1066,":[94,190],"analog":[96],"caffeic":[98],"acid":[99],"benzyl":[100],"ester":[101],"(CABE,":[102],"component":[104],"propolis),":[106],"inhibitor":[110],"STAT3":[113],"(STAT3-Y705)":[114],"WP1066":[119,136,160,173,242,284],"currently":[121],"undergoing":[122],"preclinical":[123],"development":[124],"has":[126],"multiple":[131],"cancer":[132],"models":[133],"similarly":[137],"able":[141],"BBB.":[144],"The":[145,218],"goal":[146],"this":[148],"study":[149,221],"assess":[152],"therapeutic":[153,248],"effects":[154],"combination":[158,209,240,282],"the":[162],"vitro":[164],"vivo":[167,211],"GBM":[168,180,227],"RESULTS:":[170],"were":[174],"tested":[175,214],"panel":[178],"cell":[181,185],"lines":[182],"GSC":[184],"lines.":[186],"Both,":[187],"induce":[192],"apoptosis":[193],"inhibit":[195],"cells":[196],"growth":[197,234],"at":[198],"low":[199],"micromolar":[202],"concentrations,":[203],"respectively.":[204],"Dosing":[205],"schedule":[206],"for":[207,294],"therapy":[212],"CD-1":[216],"mice.":[217],"proof-of-principle":[219],"efficacy":[220],"performed":[223],"subcutaneous":[225],"U87":[226],"model":[229],"superior":[232],"inhibition":[235],"group":[238],"receiving":[239],"WP744.":[244],"CONCLUSION:":[245],"Proposed":[246],"novel":[247],"strategy":[249],"involving":[250],"two":[251],"compounds":[252],"(WP744":[253],"WP1066)":[255],"significant":[257],"CNS":[258],"uptake":[259],"are":[261],"mechanistically":[262],"complementary":[263],"highly":[265],"promising":[266],"results":[269],"warrant":[270],"further":[271],"evaluation":[272],"different":[274],"Consistent":[278],"broader":[287],"range":[288],"would":[291],"open":[292],"possibility":[293],"its":[295],"future":[296],"evaluation.":[298]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":4}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2025-10-10T00:00:00"}